Changes in the levels of testosterone profile over time in relation to clinical parameters in a cohort of patients with prostate cancer managed by active surveillance.

Ahmed S ZakariaAlice DragomirWassim KassoufSimon TanguayArmen Aprikian

Published in: World journal of urology (2018)

Our study results showed that testosterone profile measurements tended to decrease over time in PCa patients managed with AS. Free testosterone was a significant independent variable of disease progression.

Keyphrases

prostate cancer
replacement therapy
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
patient reported outcomes